Glucocorticoid pathways in chronic obstructive pulmonary disease therapy.
暂无分享,去创建一个
[1] K. J. Macleod,et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma , 2002, Thorax.
[2] P. Paré,et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. , 2001, American journal of respiratory and critical care medicine.
[3] P. Barnes,et al. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[4] A. Munck,et al. Glucocorticoid receptors: ATP and cell cycle dependence, phosphorylation, and hormone resistance. , 1996, American journal of respiratory and critical care medicine.
[5] J. Saklatvala,et al. Dexamethasone Causes Sustained Expression of Mitogen-Activated Protein Kinase (MAPK) Phosphatase 1 and Phosphatase-Mediated Inhibition of MAPK p38 , 2002, Molecular and Cellular Biology.
[6] J. Cidlowski,et al. Proteasome-mediated Glucocorticoid Receptor Degradation Restricts Transcriptional Signaling by Glucocorticoids* , 2001, The Journal of Biological Chemistry.
[7] P. Paré,et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[8] O. Kassel,et al. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP‐1 , 2001, The EMBO journal.
[9] I. Adcock,et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.
[10] P. Jones,et al. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations , 2003, European Respiratory Journal.
[11] M. Fornerod,et al. Nucleocytoplasmic Transport: The Last 200 Nanometers , 1998, Cell.
[12] A. V. van Kuilenburg,et al. Histone deacetylases (HDACs): characterization of the classical HDAC family. , 2003, The Biochemical journal.
[13] K. Shirato,et al. Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD , 2003, Thorax.
[14] I. Adcock. Glucocorticoids: New mechanisms and future agents , 2003, Current allergy and asthma reports.
[15] J. Bousquet,et al. Corticosteroid reversibility in COPD is related to features of asthma. , 1997, American journal of respiratory and critical care medicine.
[16] S. Logan,et al. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[17] W. MacNee,et al. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[18] S. Kleinert,et al. COPD—a neglected disease , 2004, The Lancet.
[19] J. McNally,et al. The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. , 2000, Science.
[20] D. DeFranco,et al. Protracted nuclear export of glucocorticoid receptor limits its turnover and does not require the exportin 1/CRM1-directed nuclear export pathway. , 2000, Molecular endocrinology.
[21] I. Adcock,et al. Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12 , 2000, Molecular and Cellular Biology.
[22] J. Wong,et al. A role for cofactor–cofactor and cofactor–histone interactions in targeting p300, SWI/SNF and Mediator for transcription , 2003, The EMBO journal.
[23] A. Munck,et al. Cell cycle-dependent glucocorticoid receptor phosphorylation and activity. , 1994, Molecular endocrinology.
[24] K. Chung,et al. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. , 2000, American journal of respiratory and critical care medicine.
[25] R. Haché,et al. Discrimination between NL1- and NL2-Mediated Nuclear Localization of the Glucocorticoid Receptor , 1999, Molecular and Cellular Biology.
[26] I. Adcock,et al. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. , 2002, The Journal of allergy and clinical immunology.
[27] M. V. Van Kerkhove,et al. Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[28] Philip Jacobs,et al. Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity. , 2004, The American journal of medicine.
[29] C. Glass,et al. Coregulator Codes of Transcriptional Regulation by Nuclear Receptors* , 2001, The Journal of Biological Chemistry.
[30] W. MacNee,et al. Oxidative stress and regulation of glutathione in lung inflammation. , 2000, The European respiratory journal.
[31] F. Santini,et al. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. , 1996, Journal of immunology.
[32] P. Shah,et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[33] M. Garabedian,et al. Phosphorylation and Inhibition of Rat Glucocorticoid Receptor Transcriptional Activation by Glycogen Synthase Kinase-3 (GSK-3) , 1998, The Journal of Biological Chemistry.
[34] Konstantinos Kostikas,et al. Oxidative stress in expired breath condensate of patients with COPD. , 2003, Chest.
[35] G. Blobel,et al. Karyopherins and nuclear import. , 2001, Current opinion in structural biology.
[36] G. Hager,et al. Structure and Dynamic Properties of a Glucocorticoid Receptor-Induced Chromatin Transition , 2000, Molecular and Cellular Biology.
[37] J. Cidlowski,et al. Immunocytochemical analysis of hormone mediated nuclear translocation of wild type and mutant glucocorticoid receptors , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[38] G. Fitzmaurice,et al. Effects of inhaled glucocorticoids on bone density in premenopausal women , 2002 .
[39] W. Maziak,et al. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[40] I. Adcock,et al. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] N. Hirasawa,et al. Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells. , 1998, Journal of immunology.
[42] M. Karin,et al. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.
[43] N. Dean,et al. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. , 1999, Biochemistry.
[44] R. Pauwels,et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.
[45] I. Rahman. Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. , 2002, Biochemical pharmacology.
[46] N. Thomson,et al. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. , 2003, American journal of respiratory and critical care medicine.
[47] P. Jeffery,et al. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. , 2002, American journal of respiratory and critical care medicine.
[48] A. Wolffe,et al. Chromatin remodeling and transcriptional activation: the cast (in order of appearance) , 2001, Oncogene.
[49] K. Yamamoto,et al. Importin 7 and Importin / Importin Are Nuclear Import Receptors for the Glucocorticoid Receptor , 2003 .
[50] W. MacNee,et al. Oxidative stress and lung inflammation in airways disease. , 2001, European journal of pharmacology.
[51] D. DeFranco,et al. Inhibition of Glucocorticoid Receptor Nucleocytoplasmic Shuttling by Okadaic Acid Requires Intact Cytoskeleton* , 1999, The Journal of Biological Chemistry.
[52] T. Archer,et al. Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter , 1998, The EMBO journal.
[53] K. Umesono,et al. Redox-dependent Regulation of Nuclear Import of the Glucocorticoid Receptor* , 1999, The Journal of Biological Chemistry.
[54] P. Barnes,et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory cell and molecular biology.
[55] B. O’Malley,et al. Progesterone and Glucocorticoid Receptors Recruit Distinct Coactivator Complexes and Promote Distinct Patterns of Local Chromatin Modification , 2003 .
[56] J. Wedzicha,et al. Exacerbations of chronic obstructive pulmonary disease. , 2003, Respiratory care.
[57] Joseph A. DiDonato,et al. Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.
[58] K. Yamamoto,et al. Two signals mediate hormone‐dependent nuclear localization of the glucocorticoid receptor. , 1987, The EMBO journal.
[59] N. Tzanakis,et al. Diagnosis and treatment of chronic obstructive pulmonary disease: evidence-based medicine. , 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[60] I. Adcock,et al. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. , 2004, The Journal of allergy and clinical immunology.
[61] A. Munck,et al. Hormone-induced hyperphosphorylation of specific phosphorylated sites in the mouse glucocorticoid receptor , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[62] P. Barnes,et al. New concepts in chronic obstructive pulmonary disease. , 2003, Annual review of medicine.
[63] Michael Karin,et al. The control of mRNA stability in response to extracellular stimuli. , 2002, Molecules and cells.
[64] C. Xiao,et al. Nuclear targeting signal recognition: a key control point in nuclear transport? , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[65] I. Adcock,et al. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. , 2004, Biochemical and biophysical research communications.
[66] A. Muñoz,et al. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. , 1997, Genes & development.
[67] Ralf Janknecht,et al. Transcriptional control: Versatile molecular glue , 1996, Current Biology.
[68] H. Magnussen,et al. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. , 2001, Respiratory medicine.
[69] N. Anthonisen,et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.
[70] P. Barnes,et al. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD , 2003, Thorax.
[71] D. DeFranco,et al. Cell cycle regulation of glucocorticoid receptor function. , 1992, The EMBO journal.
[72] J. Saklatvala,et al. Dexamethasone Destabilizes Cyclooxygenase 2 mRNA by Inhibiting Mitogen-Activated Protein Kinase p38 , 2001, Molecular and Cellular Biology.
[73] K. Kaestner,et al. DNA Binding of the Glucocorticoid Receptor Is Not Essential for Survival , 1998, Cell.
[74] J. Swantek,et al. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK , 1997, Molecular and cellular biology.
[75] P. Barnes,et al. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[76] P. Barnes,et al. Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[77] L. Fabbri,et al. Cellular and structural bases of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[78] M. Kawata,et al. Shuttling components of nuclear import machinery involved in nuclear translocation of steroid receptors exit nucleus via exportin-1/CRM-1* independent pathway. , 2004, Biochimica et biophysica acta.
[79] D. DeFranco,et al. Effects of okadaic acid, a protein phosphatase inhibitor, on glucocorticoid receptor-mediated enhancement. , 1992, Molecular endocrinology.
[80] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. , 2001, Respiratory care.
[81] P. Herrlich,et al. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor , 2001, The EMBO journal.
[82] B. Celli. ATS standards for the optimal management of chronic obstructive pulmonary disease. , 1997, Respirology.
[83] N. Lazzeri,et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. , 2000, American journal of respiratory and critical care medicine.
[84] B. Darimont,et al. Novel glucocorticoid receptor coactivator effector mechanisms , 2001, Trends in Endocrinology & Metabolism.
[85] P. Barnes,et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. , 1997, American journal of respiratory and critical care medicine.
[86] P. Barnes. COPD: is there light at the end of the tunnel? , 2004, Current opinion in pharmacology.
[87] Alan D. Lopez,et al. The global burden of disease, 1990–2020 , 1998, Nature Medicine.
[88] A. Buist. Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.